Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis.

Nelson DS, Marano RL, Joo Y, Tian SY, Patel B, Kaplan DH, Shlomchik MJ, Stevenson K, Bronson RT, Rollins BJ.

PLoS One. 2019 Sep 17;14(9):e0222400. doi: 10.1371/journal.pone.0222400. eCollection 2019.

2.

American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond-Lessons Learned and Member Institutions' Perspectives.

Micheel CM, Sweeney SM, LeNoue-Newton ML, André F, Bedard PL, Guinney J, Meijer GA, Rollins BJ, Sawyers CL, Schultz N, Shaw KRM, Velculescu VE, Levy MA; AACR Project GENIE Consortium.

JCO Clin Cancer Inform. 2018 Dec;2:1-14. doi: 10.1200/CCI.17.00083. Review.

3.

Histiocytoses: emerging neoplasia behind inflammation.

Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, Vaglio A, Abdel-Wahab O, Emile JF, Amoura Z.

Lancet Oncol. 2017 Feb;18(2):e113-e125. doi: 10.1016/S1470-2045(17)30031-1. Review.

PMID:
28214412
4.

Institutional implementation of clinical tumor profiling on an unselected cancer population.

Sholl LM, Do K, Shivdasani P, Cerami E, Dubuc AM, Kuo FC, Garcia EP, Jia Y, Davineni P, Abo RP, Pugh TJ, van Hummelen P, Thorner AR, Ducar M, Berger AH, Nishino M, Janeway KA, Church A, Harris M, Ritterhouse LL, Campbell JD, Rojas-Rudilla V, Ligon AH, Ramkissoon S, Cleary JM, Matulonis U, Oxnard GR, Chao R, Tassell V, Christensen J, Hahn WC, Kantoff PW, Kwiatkowski DJ, Johnson BE, Meyerson M, Garraway LA, Shapiro GI, Rollins BJ, Lindeman NI, MacConaill LE.

JCI Insight. 2016 Nov 17;1(19):e87062. doi: 10.1172/jci.insight.87062.

5.

CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.

Chen X, Wang Y, Nelson D, Tian S, Mulvey E, Patel B, Conti I, Jaen J, Rollins BJ.

PLoS One. 2016 Nov 7;11(11):e0165595. doi: 10.1371/journal.pone.0165595. eCollection 2016.

6.

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.

Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, Arceci RJ, Rollins BJ; Steering Committee of the Nikolas Symposium.

Pediatr Blood Cancer. 2016 Oct;63(10):1704-12. doi: 10.1002/pbc.26104. Epub 2016 Jun 17. Review.

PMID:
27314817
7.

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society.

Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10. Review.

8.

Congenital and Acquired Disorders of Macrophages and Histiocytes.

Berliner N, Rollins BJ.

Hematol Oncol Clin North Am. 2015 Oct;29(5):xiii-xv. doi: 10.1016/j.hoc.2015.07.001. Epub 2015 Aug 14. No abstract available.

PMID:
26461161
9.

Genomic Alterations in Langerhans Cell Histiocytosis.

Rollins BJ.

Hematol Oncol Clin North Am. 2015 Oct;29(5):839-51. doi: 10.1016/j.hoc.2015.06.004. Review.

PMID:
26461146
10.

Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.

MacConaill LE, Lindeman NI, Rollins BJ.

JAMA Oncol. 2015 Oct;1(7):879-80. doi: 10.1001/jamaoncol.2015.1540. No abstract available.

PMID:
26181886
11.

MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.

Nelson DS, van Halteren A, Quispel WT, van den Bos C, Bovée JV, Patel B, Badalian-Very G, van Hummelen P, Ducar M, Lin L, MacConaill LE, Egeler RM, Rollins BJ.

Genes Chromosomes Cancer. 2015 Jun;54(6):361-8. doi: 10.1002/gcc.22247. Epub 2015 Mar 31.

PMID:
25899310
12.

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D, Dubuc A, Brown L, Burns M, Cryan JB, Abedalthagafi M, Kang YJ, Schultz N, Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L, Ruland S, Doherty LM, LaFrankie DC, Horvath M, Aizer AA, Russo A, Arvold ND, Claus EB, Al-Mefty O, Johnson MD, Golby AJ, Dunn IF, Chiocca EA, Trippa L, Santagata S, Folkerth RD, Kantoff P, Rollins BJ, Lindeman NI, Wen PY, Ligon AH, Beroukhim R, Alexander BM, Ligon KL.

Neuro Oncol. 2015 Oct;17(10):1344-55. doi: 10.1093/neuonc/nov015. Epub 2015 Mar 9.

13.

Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

MacConaill LE, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, Byrne M, Chung L, Conneely J, Crosby L, Garraway LA, Gong X, Hahn WC, Hatton C, Kantoff PW, Kluk M, Kuo F, Jia Y, Joshi R, Longtine J, Manning A, Palescandolo E, Sharaf N, Sholl L, van Hummelen P, Wade J, Wollinson BM, Zepf D, Rollins BJ, Lindeman NI.

J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.

14.

Physicians' attitudes about multiplex tumor genomic testing.

Gray SW, Hicks-Courant K, Cronin A, Rollins BJ, Weeks JC.

J Clin Oncol. 2014 May 1;32(13):1317-23. doi: 10.1200/JCO.2013.52.4298. Epub 2014 Mar 24.

15.

Somatic activating ARAF mutations in Langerhans cell histiocytosis.

Nelson DS, Quispel W, Badalian-Very G, van Halteren AG, van den Bos C, Bovée JV, Tian SY, Van Hummelen P, Ducar M, MacConaill LE, Egeler RM, Rollins BJ.

Blood. 2014 May 15;123(20):3152-5. doi: 10.1182/blood-2013-06-511139. Epub 2014 Mar 20.

PMID:
24652991
16.

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate.

Bates SV, Lakshmanan A, Green AL, Terry J, Badalian-Very G, Rollins BJ, Fleck P, Aslam M, Degar BA.

AJP Rep. 2013 Oct;3(2):63-6. doi: 10.1055/s-0033-1338168. Epub 2013 Mar 18.

17.

Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.

Liu Y, Quang P, Braggio E, Ngo H, Badalian-Very G, Flores L, Zhang Y, Sacco A, Maiso P, Azab AK, Azab F, Carrasco R, Rollins BJ, Roccaro AM, Ghobrial IM.

PLoS One. 2013 Jun 13;8(6):e66982. doi: 10.1371/journal.pone.0066982. Print 2013.

18.

Pathogenesis of Langerhans cell histiocytosis.

Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ.

Annu Rev Pathol. 2013 Jan 24;8:1-20. doi: 10.1146/annurev-pathol-020712-163959. Epub 2012 Aug 6. Review.

PMID:
22906202
19.

Recent advances in the understanding of Langerhans cell histiocytosis.

Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ.

Br J Haematol. 2012 Jan;156(2):163-72. doi: 10.1111/j.1365-2141.2011.08915.x. Epub 2011 Oct 24. Review.

PMID:
22017623
20.

Recurrent BRAF mutations in Langerhans cell histiocytosis.

Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ.

Blood. 2010 Sep 16;116(11):1919-23. doi: 10.1182/blood-2010-04-279083. Epub 2010 Jun 2.

21.

The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.

Collington SJ, Hallgren J, Pease JE, Jones TG, Rollins BJ, Westwick J, Austen KF, Williams TJ, Gurish MF, Weller CL.

J Immunol. 2010 Jun 1;184(11):6114-23. doi: 10.4049/jimmunol.0904177. Epub 2010 Apr 28.

22.

Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one?

Degar BA, Rollins BJ.

Dis Model Mech. 2009 Sep-Oct;2(9-10):436-9. doi: 10.1242/dmm.004010.

23.

Where the confusion began: cloning the first chemokine receptors.

Rollins BJ.

J Immunol. 2009 Sep 1;183(5):2893-4. doi: 10.4049/jimmunol.0990065. No abstract available.

24.

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Azab AK, Azab F, Blotta S, Pitsillides CM, Thompson B, Runnels JM, Roccaro AM, Ngo HT, Melhem MR, Sacco A, Jia X, Anderson KC, Lin CP, Rollins BJ, Ghobrial IM.

Blood. 2009 Jul 16;114(3):619-29. doi: 10.1182/blood-2009-01-199281. Epub 2009 May 14.

25.

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, Azab F, Runnels J, Jia X, Ngo HT, Melhem MR, Lin CP, Ribatti D, Rollins BJ, Witzig TE, Anderson KC, Ghobrial IM.

Blood. 2009 Jun 25;113(26):6669-80. doi: 10.1182/blood-2009-01-198408. Epub 2009 Apr 28.

26.

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Azab AK, Runnels JM, Pitsillides C, Moreau AS, Azab F, Leleu X, Jia X, Wright R, Ospina B, Carlson AL, Alt C, Burwick N, Roccaro AM, Ngo HT, Farag M, Melhem MR, Sacco A, Munshi NC, Hideshima T, Rollins BJ, Anderson KC, Kung AL, Lin CP, Ghobrial IM.

Blood. 2009 Apr 30;113(18):4341-51. doi: 10.1182/blood-2008-10-186668. Epub 2009 Jan 12.

27.

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

Roccaro AM, Sacco A, Chen C, Runnels J, Leleu X, Azab F, Azab AK, Jia X, Ngo HT, Melhem MR, Burwick N, Varticovski L, Novina CD, Rollins BJ, Anderson KC, Ghobrial IM.

Blood. 2009 Apr 30;113(18):4391-402. doi: 10.1182/blood-2008-09-178228. Epub 2008 Dec 12.

28.

Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.

Alexis JD, Pyo RT, Chereshnev I, Katz J, Rollins BJ, Charo IF, Taubman MB.

J Vasc Res. 2008;45(6):538-46. doi: 10.1159/000129688. Epub 2008 May 7.

PMID:
18463419
29.

Innocents abroad: regulating where naive T cells go.

Rollins BJ.

Nat Immunol. 2008 Mar;9(3):233-5. doi: 10.1038/ni0308-233. No abstract available.

PMID:
18285773
30.

Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue.

Inouye KE, Shi H, Howard JK, Daly CH, Lord GM, Rollins BJ, Flier JS.

Diabetes. 2007 Sep;56(9):2242-50. Epub 2007 May 1.

31.

Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.

Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, Kraemer D, Taffet G, Rollins BJ, Entman ML.

Circulation. 2007 Feb 6;115(5):584-92.

PMID:
17283277
32.

Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ, Tesch GH.

Diabetologia. 2007 Feb;50(2):471-80. Epub 2006 Dec 12.

PMID:
17160673
33.

The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo.

Martin AP, Canasto-Chibuque C, Shang L, Rollins BJ, Lira SA.

J Immunol. 2006 Nov 15;177(10):7296-302.

34.

Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells.

Khan WI, Motomura Y, Wang H, El-Sharkawy RT, Verdu EF, Verma-Gandhu M, Rollins BJ, Collins SM.

Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G803-11. Epub 2006 May 25.

35.

Inflammatory chemokines in cancer growth and progression.

Rollins BJ.

Eur J Cancer. 2006 Apr;42(6):760-7. Epub 2006 Feb 28. Review.

PMID:
16510278
36.

Release the hounds! A chemokine elicits monocytes from bone marrow.

Rollins BJ.

Nat Immunol. 2006 Mar;7(3):230-2. No abstract available.

PMID:
16482169
37.

The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection.

Depaolo RW, Lathan R, Rollins BJ, Karpus WJ.

Infect Immun. 2005 Oct;73(10):6514-22.

38.

Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice.

Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, Stein EJ, Kish J, Tani M, Charo IF, Proudfoot AE, Rollins BJ, Handel T, Ransohoff RM.

FASEB J. 2005 May;19(7):761-72.

PMID:
15857890
39.

CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.

Zhang T, Somasundaram R, Berencsi K, Caputo L, Rani P, Guerry D, Furth E, Rollins BJ, Putt M, Gimotty P, Swoboda R, Herlyn M, Herlyn D.

J Immunol. 2005 May 1;174(9):5856-63.

40.

The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation.

Ferreira AM, Rollins BJ, Faunce DE, Burns AL, Zhu X, Dipietro LA.

Cytokine. 2005 Apr 21;30(2):64-71.

PMID:
15804597
41.

CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.

Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG.

Circ Res. 2005 Apr 29;96(8):881-9. Epub 2005 Mar 17.

PMID:
15774854
42.

Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.

Waeckel L, Mallat Z, Potteaux S, Combadière C, Clergue M, Duriez M, Bao L, Gerard C, Rollins BJ, Tedgui A, Levy BI, Silvestre JS.

Circ Res. 2005 Mar 18;96(5):576-82. Epub 2005 Feb 17.

PMID:
15718500
43.

Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.

Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, Koni PA, Gurish MF.

Blood. 2005 Jun 1;105(11):4308-13. Epub 2005 Feb 10.

44.

The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation.

Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ, Bornstein P.

Am J Pathol. 2004 Dec;165(6):2157-66.

45.

Differential roles of CCL2 and CCR2 in host defense to coronavirus infection.

Held KS, Chen BP, Kuziel WA, Rollins BJ, Lane TE.

Virology. 2004 Nov 24;329(2):251-60.

46.

Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2.

Koth LL, Rodriguez MW, Bernstein XL, Chan S, Huang X, Charo IF, Rollins BJ, Erle DJ.

Respir Res. 2004 Sep 15;5:12.

47.

CCL2 (monocyte chemoattractant protein-1) and cancer.

Conti I, Rollins BJ.

Semin Cancer Biol. 2004 Jun;14(3):149-54. Review.

PMID:
15246049
48.

Cyclin C/cdk3 promotes Rb-dependent G0 exit.

Ren S, Rollins BJ.

Cell. 2004 Apr 16;117(2):239-51.

49.

Chemokine-based pathogenetic mechanisms in cancer.

Conti I, Dube C, Rollins BJ.

Novartis Found Symp. 2004;256:29-41; discussion 41-52, 266-9. Review.

PMID:
15027482
50.

MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells.

Schecter AD, Berman AB, Yi L, Ma H, Daly CM, Soejima K, Rollins BJ, Charo IF, Taubman MB.

J Leukoc Biol. 2004 Jun;75(6):1079-85. Epub 2004 Mar 12.

PMID:
15020650

Supplemental Content

Loading ...
Support Center